Does ERLOTINIB Cause Lung neoplasm malignant? 193 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 193 reports of Lung neoplasm malignant have been filed in association with ERLOTINIB (Erlotinib). This represents 0.9% of all adverse event reports for ERLOTINIB.
193
Reports of Lung neoplasm malignant with ERLOTINIB
0.9%
of all ERLOTINIB reports
162
Deaths
33
Hospitalizations
How Dangerous Is Lung neoplasm malignant From ERLOTINIB?
Of the 193 reports, 162 (83.9%) resulted in death, 33 (17.1%) required hospitalization, and 3 (1.6%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERLOTINIB. However, 193 reports have been filed with the FAERS database.
What Other Side Effects Does ERLOTINIB Cause?
Death (5,000)
Rash (4,648)
Diarrhoea (3,448)
Fatigue (1,548)
Nausea (1,366)
Drug ineffective (1,207)
Off label use (1,190)
Decreased appetite (998)
Malignant neoplasm progression (954)
Dry skin (953)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which ERLOTINIB Alternatives Have Lower Lung neoplasm malignant Risk?
ERLOTINIB vs ERTAPENEM
ERLOTINIB vs ERTUGLIFLOZIN PIDOLATE
ERLOTINIB vs ERYTHROMYCIN
ERLOTINIB vs ERYTHROMYCIN ETHYLSUCCINATE
ERLOTINIB vs ERYTHROMYCIN LACTOBIONATE